Neuronal nicotinic acetylcholine receptor (nAChR) (nAChR)

Neuronal nicotinic acetylcholine receptors (nAChRs) are pentameric ligand-gated ion channels that mediate fast excitatory neurotransmission and modulate the release of various neurotransmitters in the brain [1]. The alpha-4 beta-2 (alpha4beta2) and alpha-6 beta-2 (alpha6beta2) subtypes are the most prevalent heteromeric nAChRs in the central nervous system and serve as critical regulators of the dopaminergic system [3, 6]. The alpha4beta2 subtype is widely expressed and possesses a high affinity for nicotine, making it the primary mediator of nicotine's reinforcing effects and a key target for smoking cessation therapies like varenicline [4, 11]. In contrast, the alpha6beta2 subtype is more selectively localized to dopaminergic terminals in the striatum and midbrain, where it plays a specialized role in modulating dopamine signaling and is a potential target for Parkinson's disease [2, 7]. These receptors are significant therapeutic targets for neurodegenerative diseases, cognitive disorders, and psychiatric conditions such as depression and anxiety [1, 9]. Pharmacological agents targeting these receptors include full and partial agonists, which can enhance cognitive function or aid in addiction recovery, and antagonists used to block receptor activity or study receptor function [5, 8]. Chronic exposure to nicotine leads to the up-regulation of alpha4beta2 receptors and the down-regulation of alpha6beta2 receptors, contributing to the complex neuroadaptations seen in tobacco dependence [6, 10]. Safety concerns for drugs targeting these receptors include gastrointestinal distress, sleep disturbances, and potential cardiovascular or neuropsychiatric side effects [5, 11].

Other names

Cholinergic receptor nicotinicHeteromeric nicotinic acetylcholine receptoralpha-4 beta-2 nicotinic receptoralpha-6 beta-2 nicotinic receptoralpha4beta2 nAChRalpha6beta2 nAChR

Agonism, partial agonism, antagonism, and desensitization of the ligand-gated ion channel to modulate cation influx and neurotransmitter release [1, 5, 7].